, Volume 29, Issue 7, pp 699-706
Date: 24 Jun 2012

Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

This short review offers an update on the first and second Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) for patients with melanoma, and briefly traces the development of intraoperative lymphatic mapping and sentinel node biopsy.

Presented at the Fourth International Symposium on Cancer Metastasis and the Lymphovascular System, May 12, 2011, New York, NY.
This article was conducted on behalf of the MSLT Study Group.
The details of the Multicenter Selective Lymphadenectomy Trial participants are given in Appendix.